The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,958.00
Bid: 1,957.00
Ask: 1,960.00
Change: 0.00 (0.00%)
Spread: 3.00 (0.153%)
Open: 1,969.00
High: 1,972.00
Low: 1,955.00
Prev. Close: 1,958.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATING CHANGES: JP Morgan Raises Schroders Price Target

Fri, 08th Nov 2013 10:11

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
BERENBERG CUTS WEIR GROUP PRICE TARGET TO 2,675 (2,680) PENCE - 'BUY'
----------
S&P CAPITAL IQ CUTS MORRISON PRICE TARGET TO 305 (315) PENCE - 'HOLD'
----------
SOCGEN RAISES SCHRODERS PRICE TARGET TO 2555 (2460) PENCE
----------
UBS RAISES SCHRODERS PRICE TARGET TO 2,450 (2,350) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SCHRODERS PRICE TARGET TO 2,791 (2,624) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES ASSOCIATED BRITISH FOODS TO 'HOLD' ('RED.') - TP 2,062 (1,845) P.
----------
CANACCORD RAISES AB FOODS PRICE TARGET TO 1680 (1663) PENCE - 'SELL'
----------
DEUTSCHE BANK RAISES RANDGOLD PRICE TARGET TO 5200 (5050) PENCE - 'BUY'
----------
BARCLAYS CUTS COCA-COLA HBC AG TO 'EQUAL WEIGHT' ('OVERW.') - PT 1,825 (2,000) P
----------
GOLDMAN RAISES ANGLO AMERICAN PRICE TARGET TO 1,130 (1,100) PENCE - 'SELL'
----------
FTSE 250
----------
LIBERUM RAISES CENTAMIN PRICE TARGET TO 81 (70) PENCE - 'BUY'
----------
MORGAN STANLEY CUTS INMARSAT PRICE TARGET TO 740 (820) PENCE
----------
BARCLAYS CUTS INMARSAT TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 705 (780) P.
----------
UBS CUTS INMARSAT PRICE TARGET TO 695 (715) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS INMARSAT PRICE TARGET TO 780 (800) PENCE - 'OVERWEIGHT'
----------
CITIGROUP RAISES HALFORDS GROUP PRICE TARGET TO 545 (465) PENCE - 'BUY'
----------
JPMORGAN RAISES HALFORDS GROUP PRICE TARGET TO 440 (405) PENCE - 'OVERWEIGHT'
----------
DEUTSCHE BANK CUTS LANCASHIRE TO 'HOLD' ('BUY') - TARGET 807.4 (816.0) PENCE
----------
GOLDMAN RAISES BABCOCK INTERNATIONAL PRICE TARGET TO 1,750 (1,371) PENCE
----------
JPMORGAN RAISES DAIRY CREST GROUP PRICE TARGET TO 583 (543) P. - 'OVERWEIGHT'
----------
UBS RAISES BOOKER GROUP PLC PRICE TARGET TO 170 (141) PENCE - 'BUY'
----------
UBS RAISES IG GROUP PRICE TARGET TO 720 (700) PENCE - 'BUY'
----------
PANMURE RAISES BOVIS HOMES PRICE TARGET TO 875 (873) PENCE - 'BUY'
----------
NUMIS RAISES RESTAURANT GROUP TO 'HOLD' ('REDUCE') - TARGET 550 PENCE
----------
PANMURE RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1,350 (1,300) P. - 'BUY'
----------
NUMIS RAISES SYNTHOMER PRICE TARGET TO 257 (240) PENCE - 'HOLD'
----------
MORGAN STANLEY RAISES SYNTHOMER PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
ALL-SHARE AND AIM
----------
JEFFERIES RAISES SHANKS GROUP PRICE TARGET TO 121 (100) PENCE
----------
DEUTSCHE BANK RAISES RIGHTMOVE PRICE TARGET TO 2650 (2450) PENCE - 'HOLD'
----------
JPMORGAN CUTS LONDON MINING PLC PRICE TARGET TO 200 (215) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS RECORD PLC PRICE TARGET TO 40 (45) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES CLARKSON PRICE TARGET TO 1,990 (1,670) PENCE - 'NEUTRAL'
----------
NUMIS RAISES CAPITAL & REGIONAL PRICE TARGET TO 53 (50) PENCE - 'BUY'
----------
NUMIS CUTS ABCAM PRICE TARGET TO 560 (570) PENCE - 'ADD'
----------
CANACCORD CUTS ABCAM PRICE TARGET TO 386 (396) PENCE - 'SELL'
----------
LIBERUM CUTS WATERLOGIC PRICE TARGET TO 110 (120) PENCE - 'HOLD'
----------
NUMIS RAISES GRAFTON GROUP PRICE TARGET TO 720,0 (668,9) PENCE - 'ADD'
----------
CANACCORD RAISES NOVAE GROUP PRICE TARGET TO 575 (520) PENCE - 'BUY'
----------
NOMURA RAISES LONMIN PRICE TARGET TO 425 (400) PENCE - 'BUY'
----------
Copyright 2013 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.